News Center

Operation Cooperation Agreement In Relation To Overseas Market Of Cosmetics

Release time：2025-03-13 09:10

Suzhou, 12 March, 2025-Kintor Pharmaceutical Limited (“Kintor Pharma”, HKEX: 9939), announced that Suzhou Kintor Pharmaceuticals, Inc. (the “Suzhou Kintor”), a wholly-owned subsidiary of the Company, entered into a brand and sales operation cooperation agreement (the “Operation Cooperation Agreement”) with Hangzhou ToMax Co., Ltd. (杭州涂麥科技有限公司) (the “ToMax”) in relation to a business cooperation (the “Business Cooperation”) in the sales agency, brand operation and market promotion of the Company’s cosmetics including but not limited to anti-hair loss, acne treatment and skin whitening products in the overseas market.

 

Pursuant to the Operation Cooperation Agreement, the Group and ToMax reached consensus on the brand strategic operation of cosmetics in the overseas market. The parties have agreed to establish close cooperation to fully utilize the strength of each party based on the respective advantages and resources, which will advance the business development and product line extension, achieving complementary advantages, mutual benefits and win-win outcome. Such Business Cooperation mainly includes:

 

1.The Group shall be primarily responsible for the research and development, manufacturing, and quality control of cosmetics, ensuring that the products are in compliance with relevant regulations and standards, while providing complimentary samples and special promotional resources required for initial operation.

 

2.ToMax shall undertake full responsibility for marketing and promotion operations of cosmetics. This includes establishing professional operation teams, formulating and implementing precise marketing strategy, and aiming to increase the sales volume and enhance the popularity of cosmetic brand.

 

ToMax, a limited liability company established in China, is a member of Zhejiang TODO Group (浙江途達集團). Founded in March 2010 and headquartered in Hangzhou, Zhejiang Province, the TODO Group primarily engages in online and offline product marketing and brand promotion for big health products. With extensive experience in overseas sales channel operations, the TODO Group collaborates with over 800 primary and secondary suppliers and serves clients across 120 countries and regions worldwide, and the overseas sales of the TODO Group exceeded US$200 million in 2024, maintaining fast yet steady growth momentum. In the cross-border e-commerce sector, the TODO Group operates self-owned Amazon platforms, TikTok U.S. and U.K. platforms, and overseas warehouses, striving to build a B2C industry sales platform in the field of big health by multi-brand strategies, multi-channel distribution, and independent website operations.

 

Dr. Youzhi Tong, the founder, chairman and CEO of Kintor Pharma, said,"Through entering into the Operation Cooperation Agreement, we aim to fully leverage the premium resources and capabilities of both parties and jointly advance synergistic development of the cosmetics business in achieving short-term results and medium to long-term strategic objectives under the complementary collaboration model. By integrating ToMax’s professional competency in brand promotion and marketing services with the Group’s outstanding innovation and product capabilities in the field of cosmetics, the parties would like to create a synergy to expand product sales network coverage and diversify revenue streams in order to enhance market penetration rate and sustainable growth of the Group’s cosmetics business, from which the Group is expected to derive benefits."

Previous:

Long-Term Safety Phase III Clinical Trial Of KX-826 For The Treatment Of AGA Reached Primary Endpoint

Next:

First Subject Enrollment In Phase 3 Stage Of KX-826 1.0% For AGA

recommend News

Kintor